Table 1.
Clinicopathological patient data and treatment strategies
| Mean patient age | 68.1 years (range 38–91) |
|
| |
| Gender (male / female) | 86 (85.2%)/15 (14.9%) |
|
| |
| Secondary carcinoma in situ | 13 (12.9%) |
|
| |
| Mean follow-up | 42.2 months (range 15–60) |
|
| |
| Papillary / sessile or ulcerated | 77 (76.2%)/24 (23.8%) |
|
| |
| Treatment strategies | |
| TUR | 39 (38.6%) |
|
| |
| TUR + MMC | 22 (21.8%) |
|
| |
| TUR + BCG | 11 (10.9%) |
|
| |
| TUR + CT | 9 (8.9%) |
|
| |
| Radical cystectomy | 15 (14.9%) |
|
| |
| Radical cystectomy + CT | 5 (5%) |
TUR, transurethral resection; MMC, mytomycin; BCG, bacillus Calmette–Guérin; CT, chemotherapy.